Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.60% | 163.54 | 0.7% | $1305.95m | |
| LLY | Eli Lilly & Co. | -1.93% | 323.65 | 1.1% | $1056.02m | |
| ABBV | AbbVie, Inc. | -5.84% | 134.38 | 1.9% | $793.06m | |
| PFE | Pfizer Inc. | -0.75% | 43.83 | 0.9% | $778.51m | |
| BMY | Bristol-Myers Squibb Co. | -0.82% | 71.12 | 1.0% | $763.08m | |
| MRK | Merck & Co., Inc. | -0.52% | 86.19 | 0.7% | $687.90m | |
| AZN | AstraZeneca Plc | -0.13% | 54.84 | 1.0% | $411.81m | |
| NVS | Novartis AG | -0.73% | 76.01 | 0.2% | $216.26m | |
| GSK | GSK Plc | 0.31% | 29.45 | 0.3% | $214.53m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -4.41% | 200.16 | 8.2% | $210.64m | |
| GBT | Global Blood Therapeutics, Inc. | 0.04% | 68.10 | 5.4% | $190.73m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.21% | 151.22 | 0.0% | $178.64m | |
| IDXX | IDEXX Laboratories, Inc. | -1.81% | 325.80 | 3.9% | $175.84m | |
| HZNP | Horizon Therapeutics Plc | -1.28% | 61.89 | 5.4% | $160.55m | |
| NVO | Novo Nordisk A/S | -0.74% | 99.65 | 0.1% | $140.44m |
Company Profile
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Salt Lake City, UT.